These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25354742)

  • 1. [Optimization of technological processes for the preparation of tablets with a low content of warfarin by direct compression].
    Muselík J; Franc A; Starková J; Matějková Z
    Ceska Slov Farm; 2014 Oct; 63(5):217-21. PubMed ID: 25354742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of content uniformity of tablets with a low content of the active ingredient with a narrow therapeutic index].
    Muselík J; Franc A
    Ceska Slov Farm; 2012 Dec; 61(6):271-5. PubMed ID: 23387856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP.
    Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I
    Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Content uniformity of warfarin-containing mixtures and tablets].
    Franc A; Muselík J; Máslová R; Hadrabová J
    Ceska Slov Farm; 2013 Aug; 62(4):177-81. PubMed ID: 24047147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of drug concentration and blending technology on the content uniformity of mixture for low dose warfarin tablets].
    Elbl J; Muselík J; Franc A; Mikušová J; Dolejší Z; Vetchý D
    Ceska Slov Farm; 2016; 65(6):211-215. PubMed ID: 28079385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixing of low-dose cohesive drug and overcoming of pre-blending step using a new gentle-wing high-shear mixer granulator.
    Alsulays BB; Fayed MH; Alalaiwe A; Alshahrani SM; Alshetaili AS; Alshehri SM; Alanazi FK
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1520-1527. PubMed ID: 29718720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor analysis in optimization of formulation of high content uniformity tablets containing low dose active substance.
    Lukášová I; Muselík J; Franc A; Goněc R; Mika F; Vetchý D
    Eur J Pharm Sci; 2017 Nov; 109():541-547. PubMed ID: 28912027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of dissolution method for warfarin sodium tablets].
    Lukášová I; Muselík J; Franc A
    Ceska Slov Farm; 2018; 66(6):281-286. PubMed ID: 29623710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raman spectroscopy as a complementary tool to assess the content uniformity of dosage units in break-scored warfarin tablets.
    Arruabarrena J; Coello J; Maspoch S
    Int J Pharm; 2014 Apr; 465(1-2):299-305. PubMed ID: 24508332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous direct compression as manufacturing platform for sustained release tablets.
    Van Snick B; Holman J; Cunningham C; Kumar A; Vercruysse J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Mar; 519(1-2):390-407. PubMed ID: 28069390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of amorphous and crystal sodium warfarin and its content uniformity on bioequivalence of tablets.
    Franc A; Muselík J; Zeman J; Lukášová I; Kurhajec S; Bartoníčková E; Galvánková L; Mika F; Dominik M; Vetchý D
    Eur J Pharm Sci; 2018 Dec; 125():120-129. PubMed ID: 30287409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Demonstration of Mixing Robustness in a Direct Compression Continuous Manufacturing Process.
    Roth WJ; Almaya A; Kramer TT; Hofer JD
    J Pharm Sci; 2017 May; 106(5):1339-1346. PubMed ID: 28153598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streamlining of the Powder Mixing Process based on a Segregation Test.
    Römerová S; Dammer O; Zámostný P
    AAPS PharmSciTech; 2021 Jun; 22(5):190. PubMed ID: 34159445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a continuous direct compression platform for low-dose drug products.
    Van Snick B; Holman J; Vanhoorne V; Kumar A; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Aug; 529(1-2):329-346. PubMed ID: 28684361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of mini-tablets with 1mm and 2mm diameter.
    Tissen C; Woertz K; Breitkreutz J; Kleinebudde P
    Int J Pharm; 2011 Sep; 416(1):164-70. PubMed ID: 21726616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity-A Review.
    Jakubowska E; Ciepluch N
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to estimate quality of binary random powder mixtures: samples of constant volume. II: Applications of equation to optimize tableting conditions.
    Egermann H; Frank P
    J Pharm Sci; 1992 Jul; 81(7):667-9. PubMed ID: 1403701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting Ideal Lubricant Mixing Time for Manufacturing Tablets by Evaluating Powder Flowability.
    Nakamura S; Yamaguchi S; Hiraide R; Iga K; Sakamoto T; Yuasa H
    AAPS PharmSciTech; 2017 Oct; 18(7):2832-2840. PubMed ID: 28357684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
    Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.